Exclusive articles:
The Race for U.S. Lithium Independence in the EV Revolution
Lithium demand is projected to quadruple by 2030, driven by the electric vehicle boom and increasing global energy storage needs.
Li-FT Power has strengthened its...
The Future of Cancer Therapy is Here
RenovoRx's TAMP™ technology delivers chemotherapy directly to tumors, reducing side effects and improving treatment efficacy.
With a projected 330% price increase, RenovoRx is gaining investor...
Investing in Biotech: Why 2024 Could Be the Year of Major Gains
2024 sees a biotech rebound, with over 15 IPOs by mid-year and capital inflows increasing across the sector.
Gene therapy and oncology are driving biotech...
America’s Fight for Uranium Freedom: Will It Ever End?
The U.S. is actively working to reduce its reliance on foreign uranium, particularly from Russia, through domestic mining and strategic reserves.
Investment in advanced nuclear...
Bright Minds Targets Epilepsy with Breakthrough 5-HT2C Agonist
Bright Minds Biosciences launches a Phase 2 trial for BMB-101, targeting drug-resistant epilepsy with high unmet needs.
The company trades at a $5M market cap,...
